There was a significant influx of CD11c+ dendritic cells in MLN of the IL-33–treated group prior to the infection; however, only a small number of these dendritic cells expressed activation markers such as CD86 (Supplemental Figure 8, A–C). The gene discussed is CD86; the disease is infection.